Survey Reveals Weight Loss Drugs Raise Healthcare Cost Worries for Major Employers in 2025
Large employers are bracing for a significant rise in healthcare costs, anticipating a 50% increase by 2025 compared to 2017 levels. A major contributor to this surge is expected to be prescription drug spending, particularly on GLP-1 medications. These drugs, which have garnered attention for their use in weight management and reducing cardiovascular risks, are proving costly, leading to concerns among employers.
For more details please visit https://hroutlook.com/2024/08/27/survey-reveals-weight-loss-drugs-raise-healthcare-cost-worries-for-major-employers-in-2025/
Comments
Post a Comment